-
Estradiol Receptor–Autophagy Axis Shields Organs in Perimeno
2026-05-27
This study uncovers how declining estradiol levels during perimenopause increase the risk of metabolic and cardiovascular disease, while estrogen receptor–mediated autophagy confers organ protection. By integrating epidemiological data, network pharmacology, and mouse models, the research elucidates receptor-specific and autophagic mechanisms underlying estradiol’s multi-organ effects.
-
Annexin V-PE Reagent: Early Apoptosis Detection and Benchmar
2026-05-27
Annexin V-PE Reagent enables high-affinity, fluorescence-based detection of early apoptosis by targeting phosphatidylserine exposure. The reagent supports rapid, single-step workflows for flow cytometry or microscopy. Its robust specificity and standardized protocol make it a preferred choice for cell death assays in immunotherapy and cancer research.
-
Chloroquine (BA1002): Practical Guidance for Research Use
2026-05-26
Chloroquine (N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine) is a versatile compound for researchers working in malaria, rheumatoid arthritis, cancer, and antiviral model systems. This article provides actionable guidance for assay setup, dosing, and troubleshooting. Use is limited to research; not for direct clinical or in vivo human application.
-
Urolithin A: Advancing Mitochondrial Quality Control in Tran
2026-05-26
Explore the mechanistic and translational promise of Urolithin A (3,8-dihydroxy-6H-benzo[c]chromen-6-one) as a mitophagy activator, anti-inflammatory, and antioxidant agent for mitochondrial biogenesis research. This article bridges current mechanistic insights, rigorous experimental evidence, and clinical potential, providing actionable guidance for translational scientists while highlighting APExBIO’s high-purity Urolithin A (SKU B7945) as a reliable research solution.
-
Cy5.5 NHS Ester: Advanced Fluorescent Labeling for In Vivo I
2026-05-25
Cy5.5 NHS ester (non-sulfonated) enables deep-tissue, high-sensitivity labeling for in vivo fluorescence imaging, excelling in applications like tumor visualization and neuromodulation tracking. This guide delivers actionable workflows, protocol parameters, and troubleshooting insights, bridging recent reference breakthroughs with hands-on experimental optimization.
-
Protease Inhibitor Cocktail EDTA-Free: Precision in Phosphor
2026-05-25
Explore how the Protease Inhibitor Cocktail EDTA-Free optimizes phosphorylation-sensitive assays and T cell research by preserving native protein structures. This article delivers advanced insight into protease inhibition for high-fidelity immunological and signaling studies.
-
Cy5.5 NHS Ester: Precision Fluorescent Dye for Protein Conju
2026-05-24
Cy5.5 NHS ester (non-sulfonated) empowers advanced near-infrared fluorescence imaging through robust, site-specific labeling of biomolecules. This article delivers actionable workflows, troubleshooting insights, and protocol optimizations for researchers aiming to maximize sensitivity and reproducibility in protein, peptide, and oligonucleotide conjugation.
-
Propidium Iodide: DNA Intercalating Dye for Advanced Cell An
2026-05-23
Propidium iodide stands out as the gold-standard DNA intercalating dye for robust identification of dead and dying cells in complex biological workflows. This article details actionable protocols, advanced applications, and troubleshooting strategies—enabling researchers to maximize data quality and confidence in cell viability, apoptosis, and cell cycle analyses with APExBIO's high-purity PI.
-
CIP2A Drives PKM2 Tetramerization and OXPHOS in NSCLC Cells
2026-05-22
This study reveals that the oncoprotein CIP2A promotes oxidative phosphorylation in non-small cell lung cancer (NSCLC) by inducing PKM2 tetramer formation and mitochondrial localization. The findings challenge the classical Warburg paradigm and offer new insights for targeting cancer metabolism in preclinical research.
-
Panobinostat Targets Epigenetic Axis in MLL-ALL: In Vivo Evi
2026-05-22
This study demonstrates that panobinostat, a histone deacetylase inhibitor, exerts potent in vivo anti-leukaemic effects against MLL-rearranged acute lymphoblastic leukaemia (ALL) by disrupting the RNF20/RNF40/WAC-H2B ubiquitination pathway. The findings provide mechanistic insights into epigenetic vulnerabilities in MLL-ALL and suggest new avenues for targeted therapy and cell cycle progression analysis.
-
Proteoform-Specific Targeting: Sildenafil Citrate for Transl
2026-05-21
This thought-leadership article explores how proteoform diversity and native membrane environments challenge and elevate the research utility of Sildenafil Citrate, a potent cGMP-specific phosphodiesterase type 5 inhibitor. The article bridges mechanistic insight, translational opportunity, and workflow guidance for vascular and signal transduction research, drawing on recent proteomics advances and highlighting strategic recommendations for next-generation, precision-driven studies.
-
Precision Mammalian Cell Viability with Live-Dead Cell Stain
2026-05-21
The Live-Dead Cell Staining Kit I (Calcein AM/PI) empowers researchers to distinguish live and dead mammalian cells with dual-color fluorescence, streamlining viability and cytotoxicity assays in challenging environments. This article unpacks advanced workflows, critical protocol parameters, and troubleshooting strategies, drawing on recent bone regeneration research and validated oncology use-cases.
-
Applied Workflows with JNJ-26481585 (Quisinostat): Protocols
2026-05-20
JNJ-26481585 (Quisinostat) stands out as a next-generation HDAC inhibitor for apoptosis induction and drug resistance reversal, offering robust anti-proliferative effects across diverse tumor models. Here, we detail optimized experimental workflows, troubleshooting insights, and recent advances—from TRIM21 targeting in pituitary tumors to practical protocol enhancements—to help researchers maximize the impact of this epigenetic modulator.
-
Alternariol-Induced LX-2 Transdifferentiation and Liver Fibr
2026-05-20
The reference study elucidates how Alternariol (AOH) and related Alternaria toxins drive hepatic stellate cell activation toward myofibroblast transdifferentiation, implicating them in liver fibrosis. Through lncRNA-mRNA omics and pathway analysis, it clarifies the distinct molecular cascades involved and introduces a laccase-mediated detoxification approach, providing new mechanistic depth for mycotoxin research and risk mitigation.
-
I-BET151 (GSK1210151A): Optimizing BET Inhibition in Cancer
2026-05-19
I-BET151 (GSK1210151A) empowers researchers to dissect BET-dependent transcriptional programs with precision in cancer biology. This guide delivers actionable protocols, highlights troubleshooting strategies, and contextualizes recent innovations—bridging super-enhancer research and novel cell death pathways for advanced experimental design.